Lactose is the most important carbohydrate in the milk of most species. Its biosynthesis takes place in the mammary gland. The molecular structures of α- and β -lactose differ in the orientation of a hydrogen- and a hydroxyl group on carbon atom no.1 in the glucose moiety. Both forms change into one another continuously. At room temperature, the equilibrium results in a ratio of about 40% α-lactose and 60% β-lactose. The fact that two forms of lactose exist which differ in molecular structure has profound effects on various properties of lactose such as crystallization behavior, crystal morphology, solid-state properties, and solubility. The intestine does not actively absorb lactose unless it is split into its two-monosaccharide components, i.e. glucose and galactose. This hydrolysis of lactose is affected by the enzyme lactase, which is produced by the epithelium cells in the brush-border of the small intestine. Thus, the capacity of mammals to digest lactose is dependent on the lactase activity in the intestine. The maximum activity of the enzyme occurs shortly after birth and declines during the weaning period, after which it remains at a relatively constant level. Genetically determined factors governing residual lactase activity also exist. Individuals having low lactase activity are called lactose malabsorbers. Lactose intolerance is a condition in which people have symptoms due to the decreased ability to digest lactose. The principal symptom of lactose intolerance is an adverse reaction to products containing lactose (primarily milk), including abdominal bloating and cramps, flatulence, diarrhea, nausea, borborygmi, and vomiting (particularly in adolescents). These appear one-half to two hours after consumption.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P09848 Gene ID: 3938.0 Gene Symbol: LCT Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/28426286 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Identification and synthesis of a novel 15 kDa beta-galactoside-binding lectin in human leukocytes. | 1992 Aug |
|
The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate. | 2001 Jan |
|
The bulk crystallization of alpha-lactose monohydrate from aqueous solution. | 2001 Jul |
|
Characterisation and disintegration properties of irradiated starch. | 2001 Jun 19 |
|
Determination of indomethacin crystallinity in the presence of excipients using diffuse reflectance near-infrared spectroscopy. | 2001 Nov |
|
Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures. | 2001 Nov |
|
Role of galectin-3 in adenocarcinoma liver metastasis. | 2001 Nov |
|
Quantifying electrostatic interactions in pharmaceutical solid systems. | 2001 Oct 4 |
|
Generation of live rat offspring by intrauterine insemination with epididymal spermatozoa cryopreserved at -196 degrees C. | 2001 Sep |
|
Effect of lacZY-marking of the 2,4-diacetyl-phloroglucinol producing Pseudomonas fluorescens-strain 5-2/4 on its physiological performance and root colonization ability. | 2002 |
|
Scaling-up of a lactose wet granulation process in Mi-Pro high shear mixers. | 2002 Dec |
|
Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM. | 2002 Jan 31 |
|
Continuous twin screw extrusion for the wet granulation of lactose. | 2002 Jun 4 |
|
Investigation of excipient type and level on drug release from controlled release tablets containing HPMC. | 2002 May |
|
Wax beads as cushioning agents during the compression of coated diltiazem pellets. | 2002 Nov |
|
Synthesis and anti-HCMV activity of novel acyclic nucleosides. | 2002 Oct |
|
The in vitro dissolution of theophylline from different types of hard shell capsules. | 2002 Oct |
|
A recombinant Saccharomyces cerevisiae strain for efficient conversion of lactose in salted and unsalted cheese whey into ethanol. | 2002 Oct |
|
Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". | 2002 Oct |
|
Purification and physicochemical characterization of a cotyledonary lectin from Luetzelburgia auriculata. | 2002 Oct |
|
The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization. | 2002 Oct |
|
Predicting the quality of powders for inhalation from surface energy and area. | 2002 Sep |
|
Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI. | 2002 Sep |
|
Development of agglomerated directly compressible diluent consisting of brittle and ductile materials. | 2003 |
|
Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. | 2003 Apr 30 |
|
Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS). | 2003 Apr 30 |
|
Influence of inverse gas chromatography measurement conditions on surface energy parameters of lactose monohydrate. | 2003 Apr 30 |
|
Synthesis of novel apionucleosides: a short and concise synthesis of 2-deoxyapio-L-furanosyl acetate from D-lactose. | 2003 Apr 4 |
|
Studies on the preparation of chitosan microcarriers cross-linked by oxidized lactose and culture of primary hepatocytes. | 2003 Aug |
|
In vitro nutritional requirements and metabolic products of pathogenic and nonpathogenic strains of Cryptobia salmositica: essential carbohydrates and amino acids. | 2003 Aug 15 |
|
Determining the compression behaviour of pharmaceutical powders from the force-distance compression profile. | 2003 Feb 18 |
|
Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions. | 2003 Feb 18 |
|
Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. | 2003 Feb 18 |
|
Carotenoid production by lactoso-negative yeasts co-cultivated with lactic acid bacteria in whey ultrafiltrate. | 2003 Jul-Aug |
|
The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. | 2003 Jun 18 |
|
Staphylococcus equorum subsp. linens, subsp. nov., a starter culture component for surface ripened semi-hard cheeses. | 2003 Mar |
|
Effects of excipients on hydrate formation in wet masses containing theophylline. | 2003 Mar |
|
Effect of aeration on the production of carotenoid pigments by Rhodotorula rubra-lactobacillus casei subsp. casei co-cultures in whey ultrafiltrate. | 2003 Mar-Apr |
|
Nutritional requirements of Pochonia chlamydospora and ARF18, fungal parasites of nematode eggs. | 2003 May |
|
The influence of carrier and drug morphology on drug delivery from dry powder formulations. | 2003 May 12 |
|
The relationship between granule growth mechanism, amount of liquid binder added and properties of the wet powder mass determined using a split bed shear tester. | 2003 May 12 |
|
Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression. | 2003 Sep |
|
Synthesis and hemolytic activity of some hederagenin diglycosides. | 2004 Aug |
|
Single-step granulation/tabletting of different grades of lactose: a comparison with high shear granulation and compression. | 2004 Jul |
|
Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry. | 2004 May |
|
Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers. | 2004 Nov |
|
Compaction of crystallographic forms of pharmaceutical granular lactoses. II. Compacts mechanical properties. | 2004 Nov |
|
Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data. | 2004 Oct 13 |
|
Blockage of Galectin-receptor Interactions by α-lactose Exacerbates Plasmodium berghei-induced Pulmonary Immunopathology. | 2016 Aug 24 |
|
Lactase Non-persistence and Lactose Intolerance. | 2017 May |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28421381
presence lactose in the food
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9237942
There was evaluated the capability of colonic bacteria to ferment lactose and the ability of L. acidophilus to modify lactose fermentation by the colonic microflora in vitro. An anaerobic continuous culture was established and inoculated with fresh samples of human feces. Lactose infusion was maintained at 25 g/d and pH at 6.7. L. acidophilus strain LA-1 (1.5 x 10(10) cells) was introduced into the fermenter on d 0 or added daily on d 0 through 4. The control was the continuous culture without the addition of lactobacilli. Rapid adaptation of colonic bacteria to lactose occurred within 1-2 d, with a significant decrease in lactose concentration and increase in beta-galactosidase activity, and lactose concentrations fell below 3 mmol/L by d 7.
Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 16:38:58 GMT 2023
by
admin
on
Fri Dec 15 16:38:58 GMT 2023
|
Record UNII |
J2B2A4N98G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
2553-6
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
LOINC |
17043-1
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
CFR |
21 CFR 168.122
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
LOINC |
2554-4
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
NCI_THESAURUS |
C68472
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
DSLD |
1133 (Number of products:14)
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
LOINC |
74438-3
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
LOINC |
51598-1
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
||
|
LOINC |
2552-8
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C28166
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
LACTOSE
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL417016
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
36218
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
17716
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
D007785
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
36219
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
6211
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | RxNorm | ||
|
J2B2A4N98G
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
J2B2A4N98G
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
DB04465
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
1535
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY | |||
|
SUB14317MIG
Created by
admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
|
PRIMARY |
Any of these components may be present:
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|